RAGE and amyloid-β peptide neurotoxicity in Alzheimer's disease
The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Abstract
Amyloid-beta peptide is central to the pathology of Alzheimer's disease, because it is neurotoxic--directly by inducing oxidant stress, and indirectly by activating microglia. A specific cell-surface acceptor site that could focus its effects on target cells has been postulated but not identified. Here we present evidence that the 'receptor for advanced glycation end products' (RAGE) is such a receptor, and that it mediates effects of the peptide on neurons and microglia. Increased expressing of RAGE in Alzheimer's disease brain indicates that it is relevant to the pathogenesis of neuronal dysfunction and death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Yan et al. reported that Aβ peptides and Aβ oligomers can bind to RAGE receptor and activate glial cells.331”
From Role of neuroinflammation in neurodegeneration development (2023) · cites this paper as [331]
In the citing paper
“Given that intracellular A β overload can induce oxidative stress and cell death [ 38-40 ]”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Enhancing A β uptake or efflux alone may increase intracellular A β -handling burden if autophagic degradation remains impaired [ 38-40 ].”
From Restores Aβ Clearance by Overcoming PCSK9–LRP1 Dysregulation and TRIB3‐Mediated Autophagy Blockade in Alzheimer's Disease (2026) · cites this paper as [38]
In the citing paper
“Apolipoprotein E3 (ApoE3), another key component of the lipoprotein‐like nanostructure, acts as an effective anti‐inflammatory molecule.[ 18 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
In the citing paper
“In addition, a key component of RAP‐RL, ApoE3, has been shown to regulate pericyte‐mediated cerebrovascular integrity and anti‐inflammatory reaction.[ 18 , 19 ]”
From Multifunctional Nanostructure RAP‐RL Rescues Alzheimer's Cognitive Deficits through Remodeling the Neurovascular Unit (2021) · cites this paper as [18]
6 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Strittmatter, W. J., Saunders, A. M., Schmechel, D., Pericak-Vance, M., Enghild, J., Salvesen, G. S., & Roses, A. D. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.5.1977 · Cited by 4,268
Hydrogen peroxide mediates amyloid β protein toxicity
Behl, C. (1994) · Cell · doi:10.1016/0092-8674(94)90131-7 · Cited by 2,074
Neurotrophic and Neurotoxic Effects of Amyloid β Protein: Reversal by Tachykinin Neuropeptides
Yankner, B. A., Duffy, L. K., & Kirschner, D. A. (1990) · Science · doi:10.1126/science.2218531 · Cited by 1,975
Osborn, L., Hession, C., Tizard, R., Vassallo, C., Luhowskyj, S., Chi-Rosso, G., & Lobb, R. (1989) · Cell · doi:10.1016/0092-8674(89)90775-7 · Cited by 1,689
Neeper, M., Schmidt, A. M., Brett, J., Yan, S. D., Wang, F., Pan, Y. C., Elliston, K., Stern, D., & Shaw, A. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)42138-2 · Cited by 1,541
Self-citationNeurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state
Pike, C., Burdick, D., Walencewicz, A., Glabe, C., & Cotman, C. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-04-01676.1993 · Cited by 1,417
Activation of microglial cells by β-amyloid protein and interferon-γ
Meda, L., Cassatella, M. A., Szendrei, G. I., Otvos, L., Baron, P., Villalba, M., Ferrari, D., & Rossi, F. (1995) · Nature · doi:10.1038/374647a0 · Cited by 1,314
Yan, S. D., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D., & Stern, D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)36966-1 · Cited by 1,306
Self-citationThe Receptor for Advanced Glycation End Products (RAGE) Is a Cellular Binding Site for Amphoterin
Hori, O., Brett, J., Slattery, T., Cao, R., Zhang, J., Chen, J. X., Nagashima, M., Lundh, E. R., Vijay, S., Nitecki, D., et al. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25752 · Cited by 1,151
Self-citationHensley, K., Carney, J. M., Mattson, M. P., Aksenova, M., Harris, M., Wu, J. F., Floyd, R. A., & Butterfield, D. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.8.3270 · Cited by 1,086
Research works printed but not linked: 4
- Haass, C. & Selkoe, D. Cell 7, 1039–1042 (1994).
- Trojanowski, J. & Lee, V. Am. J. Pathol. 144, 449–453 (1994).
- Gumkowski, F. et al. Blood Vessels 24, 11–18 (1987).
- Brett, J. et al. Am. J. Pathol. 143, 1699–1712 (1993).
Cited by
Items 401–500 of 1,027
Tezel, G., Luo, C., & Yang, X. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.06-0737 · Cited by 175
Fehrenbach, H., Weiskirchen, R., Kasper, M., & Gressner, A. M. (2001) · Hepatology · doi:10.1053/jhep.2001.28788 · Cited by 154
Is Alzheimer’s Disease Risk Modifiable?
Serrano-Pozo, A., & Growdon, J. H. (2019) · Journal of Alzheimer's Disease · doi:10.3233/jad181028 · Cited by 154
Ullah, R., Khan, M., Shah, S. A., Saeed, K. M., & Kim, M. O. (2019) · Nutrients · doi:10.3390/nu11061195 · Cited by 167
Gene expression profiling of amyloid beta peptide-stimulated human post-mortem brain microglia
Walker, D. G., Lue, L. F., & Beach, T. G. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00306-2 · Cited by 167
TheFEAR: a rapid screening instrument for generalized anxiety in elderly primary care attenders
Krasucki, C., Ryan, P., Ertan, T., Howard, R., Lindesay, J., & Mann, A. (1999) · International Journal of Geriatric Psychiatry · doi:10.1002/(sici)1099-1166(199901)14:1<60::aid-gps893>3.0.co;2-g · Cited by 54
Park, H., & Boyington, J. C. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169276 · Cited by 152
The Toxicity of Amyloid ß Oligomers
Zhao, L. N., Long, H. W., Mu, Y., & Chew, L. Y. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13067303 · Cited by 152
“Indeed, it is well known that Aβ oligomers can bind to several receptors [81–86] and initiate numerous signaling”
BackgroundSelf-citationGuo, J.-T., Yu, J., Grass, D., de Beer, F. C., & Kindy, M. S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-14-05900.2002 · Cited by 152
“Immunocytochemical analyses have found a variety of inflammatory proteins closely associated with senile plaques (Eikelenboom and Stam, 1982; Abraham et al., 1988; Rogers et al., 1992; Smith et al., 1994; Yan et al., 1996; Selkoe, 1999).”
BackgroundCheng, C., Tsuneyama, K., Kominami, R., Shinohara, H., Sakurai, S., Yonekura, H., Watanabe, T., Takano, Y., Yamamoto, H., & Yamamoto, Y. (2005) · Modern Pathology · doi:10.1038/modpathol.3800450 · Cited by 164
Akisaki, T., Sakurai, T., Takata, T., Umegaki, H., Araki, A., Mizuno, S., Tanaka, S., Ohashi, Y., Iguchi, A., Yokono, K., et al. (2006) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.632 · Cited by 152
Perini, G., Della-Bianca, V., Politi, V., Della Valle, G., Dal-Pra, I., Rossi, F., & Armato, U. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20011797 · Cited by 152
Alzheimer amyloid abeta1-42 channels: effects of solvent, pH, and Congo Red.
Hirakura, Y., Lin, M., & Kagan, B. L. (1999) · PubMed · Cited by 151
Microglial degeneration in the aging brain - bad news for neurons?
Streit, W. (2008) · Frontiers in Bioscience · doi:10.2741/2937 · Cited by 150
Hertel, C., Terzi, E., Hauser, N., Jakob-Røtne, R., Seelig, J., & Kemp, J. A. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.17.9412 · Cited by 149
Ontogeny and Functions of Central Nervous System Macrophages
Katsumoto, A., Lu, H., Miranda, A. S., & Ransohoff, R. M. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1400716 · Cited by 149
New Therapeutic Targets in the Neurovascular Pathway in Alzheimer's Disease
Zlokovic, B. V. (2008) · Neurotherapeutics · doi:10.1016/j.nurt.2008.05.011 · Cited by 151
“RAGE–A interaction on neurons can kill neurons directly by producing oxidative damage or indirectly by activating microglia.(41) Inhibition of RAGE–A interaction in the affected blood vessels blocks A influx across”
BackgroundRat, D., Schmitt, U., Tippmann, F., Dewachter, I., Theunis, C., Wieczerzak, E., Postina, R., van Leuven, F., Fahrenholz, F., & Kojro, E. (2011) · The FASEB Journal · doi:10.1096/fj.10-180133 · Cited by 148
Hwang, D. Y., Chae, K. R., Kang, T. S., Hwang, J. H., Lim, C. H., Kang, H. K., Goo, J. S., Lee, M. R., Lim, H. J., Min, S. H., et al. (2002) · The FASEB Journal · doi:10.1096/fj.01-0732com · Cited by 147
“Increased A might induce apoptotic activity by interacting with neuronal receptors, including the receptor for advanced glycation end-products (RAGE) (20), the p75 neurotrophin receptor (21), and the APP (22).”
BackgroundFueling inflammation at tumor microenvironment: the role of multiligand/rage axis
Rojas, A., Figueroa, H., & Morales, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp322 · Cited by 158
Velázquez, P., Cribbs, D. H., Poulos, T. L., & Tenner, A. J. (1997) · Nature Medicine · doi:10.1038/nm0197-77 · Cited by 154
Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer’s Disease
Cristóvão, J. S., Santos, R., & Gomes, C. M. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9812178 · Cited by 146
Aβ aggregation and possible implications in Alzheimer's disease pathogenesis
Bharadwaj, P. R., Dubey, A. K., Masters, C. L., Martins, R. N., & Macreadie, I. G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00609.x · Cited by 146
The receptor for advanced glycation endproducts (RAGE) and cardiovascular disease
Yan, S. F., Ramasamy, R., & Schmidt, A. M. (2009) · Expert Reviews in Molecular Medicine · doi:10.1017/s146239940900101x · Cited by 146
Self-citation(1998) · Europe PMC (PubMed Central) · Cited by 146
Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility
Rauvala, H., Huttunen, H. J., Fages, C., Kaksonen, M., Kinnunen, T. K., Imai, S., Raulo, E., & Kilpeläinen, I. (2000) · Matrix Biology · doi:10.1016/s0945-053x(00)00084-6 · Cited by 162
Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease
Moore, A. H., & O’Banion, M. K. (2002) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(02)00162-x · Cited by 171
Beeri, M. S., Moshier, E. L., Schmeidler, J., Godbold, J., Uribarri, J., Reddy, S., Sano, M. C., Grossman, H. T., Cai, W., Vlassara, H., et al. (2011) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2011.10.007 · Cited by 148
Ray, R., Juranek, J. K., & Rai, V. (2015) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2015.12.006 · Cited by 156
Alzheimer's Disease and the Amyloid β Protein: What Is the Role of Amyloid ?
Small, D. H., & McLean, C. A. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730443.x · Cited by 143
Glutamate release from microglia via glutamate transporter is enhanced by amyloid-beta peptide
Noda, M., Nakanishi, H., & Akaike, N. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00036-6 · Cited by 158
IL-4-Induced Selective Clearance of Oligomeric β-Amyloid Peptide1–42 by Rat Primary Type 2 Microglia
Shimizu, E., Kawahara, K., Kajizono, M., Sawada, M., & Nakayama, H. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6503 · Cited by 143
“AII (SRA) (8) and receptor for advanced glycation end products”
BackgroundNeurovascular Defects and Faulty Amyloid-β Vascular Clearance in Alzheimer's Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Journal of Alzheimer's Disease · doi:10.3233/jad-2012-129037 · Cited by 140
Sagare, A. P., Deane, R., & Zlokovic, B. V. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.07.008 · Cited by 143
“…has been found to be increased in brain endothelial cells and vascular smooth muscle cells in animal models of aging as well as in AD patients (Yan et al., 1996; Deane et al., 2003; Donahue et al.,2006; Miller et al., 2008; Silverberg et al., 2010b), whereas LRP1 expression is decreased both…”
BackgroundAlzheimer amyloid aβ1-42 channels: Effects of solvent, pH, and congo red
Hirakura, Y., Lin, M., & Kagan, B. L. (1999) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19990815)57:4<458::aid-jnr5>3.0.co;2-4 · Cited by 180
Acharya, N. K., Levin, E. C., Clifford, P. M., Han, M., Tourtellotte, R., Chamberlain, D., Pollaro, M., Coretti, N. J., Kosciuk, M. C., Nagele, E. P., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-122254 · Cited by 121
“Interestingly, DM has been shown to disturb microvascular function through mechanisms that include activation of protein kinase C, production of excessive reactive oxygen species, and cellular activation of the receptor for advanced glycation endproducts [14, 75, 76].”
Chan, K.-H., Lam, K. S.-L., Cheng, O.-Y., Kwan, J. S.-C., Ho, P. W.-L., Cheng, K. K.-Y., Chung, S. K., Ho, J. W.-M., Guo, V. Y., & Xu, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0052354 · Cited by 142
“This AGES/RAGE signaling activity upregulates activity of the transcription factor, nuclear factor kappa-B (NF-kB) [68–70].”
BackgroundMalherbe, P., Richards, J. G., Gaillard, H., Thompson, A., Diener, C., Schuler, A., & Huber, G. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00174-6 · Cited by 156
Mačkić, J. B., Bading, J. R., Ghiso, J. A., Walker, L. C., Wısnıewskı, T., Frangione, B., & Zloković, B. V. (2002) · Vascular Pharmacology · doi:10.1016/s1537-1891(02)00198-2 · Cited by 158
Differential effects between amphoterin and advanced glycation end products on colon cancer cells
Kuniyasu, H., Chihara, Y., & Kondo, H. (2003) · International Journal of Cancer · doi:10.1002/ijc.11016 · Cited by 141
Aβ-induced formation of autophagosomes is mediated by RAGE-CaMKKβ-AMPK signaling
Son, S. M., Jung, E. S., Shin, H. J., Byun, J., & Mook‐Jung, I. (2011) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2011.09.039 · Cited by 151
Na, K-ATPase α3 is a death target of Alzheimer patient amyloid-β assembly
Ohnishi, T., Yanazawa, M., Sasahara, T., Kitamura, Y., Hiroaki, H., Fukazawa, Y., Kii, I., Nishiyama, T., Kakita, A., Takeda, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1421182112 · Cited by 140
“These “Aβ receptors,” except for RAGE, have been reported to mediate toxicity of Aβ oligomers through modulating NMDA receptors (NMDAR) (11).”
BackgroundInfluentialPark, I. (2004) · Molecular Immunology · doi:10.1016/j.molimm.2003.11.027 · Cited by 140
The Possible Mechanism of Advanced Glycation End Products (AGEs) for Alzheimer’s Disease
Ko, S.-Y., Ko, H.-A., Chu, K.-H., Shieh, T.-M., Chi, T.-C., Chen, H.-I., Chang, W.-C., & Chang, S.-S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0143345 · Cited by 139
Carnosine Protects Proteins against Methylglyoxal-Mediated Modifications
Hipkiss, A. R., & Chana, H. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8806 · Cited by 141
Jordán, J., Galindo, M. F., Miller, R. J., Reardon, C. A., Getz, G. S., & LaDu, M. J. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-01-00195.1998 · Cited by 139
Liu, R., Wu, C., Zhou, D., Yang, F., Tian, S., Zhang, L., Zhang, T., & Du, G. (2012) · BMC Medicine · doi:10.1186/1741-7015-10-105 · Cited by 150
Takeda, S., Sato, N., Rakugi, H., & Morishita, R. (2011) · Molecular BioSystems · doi:10.1039/c0mb00302f · Cited by 138
RAGE: A Multi-Ligand Receptor Unveiling Novel Insights in Health and Disease
Alexiou, P., Chatzopoulou, M., Pegklidou, K., & Demopoulos, V. J. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791331086 · Cited by 138
Ellagic Acid and Its Role in Chronic Diseases
Derosa, G., Maffioli, P., & Sahebkar, A. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-41334-1_20 · Cited by 138
RAGE Axis: Animal Models and Novel Insights Into the Vascular Complications of Diabetes
Naka, Y., Bucciarelli, L. G., Wendt, T., Lee, L. K., Rong, L. L., Ramasamy, R., Yan, S. F., & Schmidt, A. M. (2004) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000133191.71196.90 · Cited by 138
Self-citationComplement Component C1q Modulates the Phagocytosis of Aβ by Microglia
Webster, S. D., Yang, A. J., Margol, L., Garzon-Rodriguez, W., Glabe, C. G., & Tenner, A. J. (2000) · Experimental Neurology · doi:10.1006/exnr.1999.7260 · Cited by 138
Herold, K., Moser, B., Chen, Y., Zeng, S., Yan, S. F., Ramasamy, R., Emond, J., Clynes, R., & Schmidt, A. M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.1206751 · Cited by 138
“In addition to AGEs, S100/calgranulins, HMGB1, and Mac-1, RAGE is also a signal transduction receptor for A and -sheet fibrils [ 30 , 31].”
BackgroundSelf-citationChen, F., Dong, R. R., Zhong, K. L., Ghosh, A., Tang, S. S., Long, Y., Hu, M. Y., Miao, M. X., Liao, J. M., Sun, H. B., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.023 · Cited by 149
Effect of TTP488 in patients with mild to moderate Alzheimer’s disease
Burstein, A. H., Grimes, I., Galasko, D. R., Aisen, P. S., Sabbagh, M., & Mjalli, A. M. (2014) · BMC Neurology · doi:10.1186/1471-2377-14-12 · Cited by 137
“Aβ is known to bind to The Receptor for Advanced Glycation Endproducts (RAGE) an immunoglobulin supergene family member expressed on multiple cell types in the brain and the periphery [3,4].”
BackgroundWang, C., Li, J., Liu, Q., Yang, R., Zhang, J. H., Cao, Y., & Sun, X. (2011) · Neuroscience Letters · doi:10.1016/j.neulet.2011.01.022 · Cited by 139
RetractedPreston, J. E., Hipkiss, A. R., Himsworth, D. T. J., Romero, I. A., & Abbott, J. N. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00058-5 · Cited by 153
Tan, J., Town, T., Mori, T., Wu, Y., Saxe, M., Crawford, F., & Mullan, M. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-20-07587.2000 · Cited by 137
D-Galactose injured neurogenesis in the hippocampus of adult mice
Zhang, Q., Li, X., Cui, X., & Zuo, P. (2005) · Neurological Research · doi:10.1179/016164105x25126 · Cited by 136
The role of microglia in human disease: therapeutic tool or target?
Cartier, N., Lewis, C.-A., Zhang, R., & Rossi, F. M. V. (2014) · Acta Neuropathologica · doi:10.1007/s00401-014-1330-y · Cited by 136
Rong, L. L., Yan, S., Wendt, T., Hans, D., Pachydaki, S., Bucciarelli, L. G., Adebayo, A., Qu, W., Lu, Y., Kostov, K., et al. (2004) · The FASEB Journal · doi:10.1096/fj.04-1900com · Cited by 136
Self-citationDisease-associated amyloid and misfolded protein aggregates activate the inflammasome
Masters, S. L., & O'Neill, L. A. J. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.01.005 · Cited by 145
Fu, W.-Y., Wang, X., & Ip, N. Y. (2019) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00402 · Cited by 133
YAZAWA, H., YU, Z.-X., TAKEDA, K., LE, Y., GONG, W., FERRANS, V. J., OPPENHEIM, J. J., LI, C. C. H., & WANG, J. M. (2001) · The FASEB Journal · doi:10.1096/fj.01-0251com · Cited by 105
AGEs‐RAGE System Mediates Atrial Structural Remodeling in the Diabetic Rat
KATO, T., YAMASHITA, T., SEKIGUCHI, A., TSUNEDA, T., SAGARA, K., TAKAMURA, M., KANEKO, S., AIZAWA, T., & FU, L. (2008) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2007.01037.x · Cited by 136
Sankarapandi, S., Zweier, J. L., Mukherjee, G., Quinn, M. T., & Huso, D. L. (1998) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1998.0658 · Cited by 136
Role of ABC Transporters in the Pathogenesis of Alzheimer’s Disease
Abuznait, A. H., & Kaddoumi, A. (2012) · ACS Chemical Neuroscience · doi:10.1021/cn300077c · Cited by 135
Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors
Guglielmotto (2010) · Frontiers in Aging Neuroscience · doi:10.3389/neuro.24.003.2010 · Cited by 134
“The role of RAGE in the pathogenesis of AD has been extensively studied, since it also binds Aβ (Yan et al., 1996), increasing its infl ux into the brain through the blood-brain barrier (Arancio et al., 2004; Takuma et al., 2009).”
RAGE and the pathogenesis of chronic kidney disease
D’Agati, V. D., & Schmidt, A. M. (2010) · Nature Reviews Nephrology · doi:10.1038/nrneph.2010.54 · Cited by 139
Self-citationSite-Specific Blockade of RAGE-VdPrevents Amyloid-β Oligomer Neurotoxicity
Sturchler, E., Galichet, A., Weibel, M., Leclerc, E., & Heizmann, C. W. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4878-07.2008 · Cited by 136
“In this regard, the receptor for advanced glycation end products (RAGE) was identified as one of the cellsurface binding sites for A (Yan et al., 1996).”
BackgroundInfluentialType 2 Diabetes and Late-Onset Alzheimer’s Disease
Cheng, D., Noble, J., Tang, M. X., Schupf, N., Mayeux, R., & Luchsinger, J. A. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000324134 · Cited by 134
“Increased expression of this receptor is observed in LOAD [”
Backgroundβ‐amyloid inhibition of long‐term potentiation is mediated via tumor necrosis factor
Wang, Q., Wu, J., Rowan, M. J., & Anwyl, R. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04457.x · Cited by 134
“…is most likely to be mediated by the binding of Ab to a receptor located on microglia, which could include a scavenger receptor (El Khoury et al., 1996), a receptor for advanced glycation end product (Yan et al., 1996) or a receptor complex including an integrin protein (Bamberger et al., 2003).”
BackgroundLittle, K., Llorián‐Salvador, M., Scullion, S., Hernández, C., Simó‐Servat, O., del Marco, À., Bosma, E. K., Vargas-Soria, M., Carranza-Naval, M. J., Bergen, T. V., et al. (2021) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2021.10.008 · Cited by 152
Microglia and inflammation: Impact on developmental brain injuries
Chew, L., Takanohashi, A., & Bell, M. (2006) · Mental Retardation and Developmental Disabilities Research Reviews · doi:10.1002/mrdd.20102 · Cited by 134
Kim, J. M., Lee, E. K., Kim, D. H., Yu, B. P., & Chung, H. Y. (2010) · AGE · doi:10.1007/s11357-009-9124-1 · Cited by 133
Yan, S. F., Yan, S. D., Ramasamy, R., & Schmidt, A. M. (2009) · Annals of Medicine · doi:10.1080/07853890902806576 · Cited by 133
Self-citationToxic Advanced Glycation End Products (TAGE) Theory in Alzheimer’s Disease
Sato, T., Shimogaito, N., Wu, X., Kikuchi, S., Yamagishi, S.-I., & Takeuchi, M. (2006) · American Journal of Alzheimer's Disease & Other Dementias® · doi:10.1177/1533317506289277 · Cited by 132
“Recently discovered links between DM and AD are indications of AGEs and increased RAGE expression in brains of patients with AD.(62,73) As AGEs are involved in diabetes complications, diabetes might influence AD brain pathology.”
BackgroundMicroglia and Alzheimer’s disease
Kalaria, R. N. (1999) · Current Opinion in Hematology · doi:10.1097/00062752-199901000-00004 · Cited by 133
New developments on the role of NMDA receptors in Alzheimer's disease
Malinow, R. (2012) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2011.09.001 · Cited by 132
Zong, H., Madden, A., Ward, M., Mooney, M. H., Elliott, C. T., & Stitt, A. W. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.133827 · Cited by 131
Evangelisti, E., Cascella, R., Becatti, M., Marrazza, G., Dobson, C. M., Chiti, F., Stefani, M., & Cecchi, C. (2016) · Scientific Reports · doi:10.1038/srep32721 · Cited by 132
Qiu, Z., Strickland, D. K., Hyman, B. T., & Rebeck, G. W. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0731393.x · Cited by 107
Hu, X., Liou, A. K. F., Leak, R. K., Xu, M., An, C., Suenaga, J., Shi, Y., Gao, Y., Zheng, P., & Chen, J. (2014) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2014.06.002 · Cited by 131
Zhang, J., Zhen, Y., Pu-Bu-Ci-Ren, Song, L.-G., Kong, W.-N., Shao, T.-M., Li, X., & Xi-qing, C. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.037 · Cited by 134
Yan, S. D., & Stern, D. M. (2005) · International Journal of Experimental Pathology · doi:10.1111/j.0959-9673.2005.00427.x · Cited by 129
“In this regard, our laboratory identified Receptor for Advanced Glycation Endproducts (RAGE) as a multiligand receptor whose repertoire of ligands included crossed b-sheet fibrils (Yan et al. 1996; Schmidt et al. 2001).”
BackgroundSelf-citationFcγRIIb mediates amyloid-β neurotoxicity and memory impairment in Alzheimer’s disease
Kam, T.-I., Song, S., Gwon, Y., Park, H., Yan, J.-J., Im, I., Choi, J.-W., Choi, T.-Y., Kim, J., Song, D.-K., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci66827 · Cited by 128
Rosales-Corral, S., Tan, D.-X., Manchester, L., & Reiter, R. J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/985845 · Cited by 128
Li, L. (2006) · PubMed · Cited by 141
Microglial phagocytosis in aging and Alzheimer's disease
Gabandé‐Rodríguez, E., Keane, L., & Capasso, M. (2020) · Journal of Neuroscience Research · doi:10.1002/jnr.24419 · Cited by 127
“Importantly, RAGE is expressed by neurons and also binds Aβ (Yan et al., 1996), mediating the toxic effects of Aβ oligomers in neurons (Arancio et al., 2004; Origlia et al., 2008).”
BackgroundHerculano, B., Tamura, M., Ohba, A., Shimatani, M., Kutsuna, N., & Hisatsune, T. (2013) · Journal of Alzheimer’s Disease · doi:10.3233/jad-2012-121324 · Cited by 126
Kong, Y., Ruan, L., Qian, L., Liu, X., & Le, Y. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.2985-10.2010 · Cited by 127
“…of A , including G protein-coupled receptor formyl peptide receptor 2, scavenger receptors, receptor of advanced glycation end products, Fc receptors, complement receptors, and CD14 (Paresce et al., 1996; Yan et al., 1996; Bard et al., 2000; Webster et al., 2000; Le et al., 2001; Liu et al., 2005).”
BackgroundNF-κB transcription factors: critical regulators of hematopoiesis and neuronal survival
Denk, A., Wirth, T., & Baumann, B. (2000) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00009-5 · Cited by 140
Leptin: A Novel Therapeutic Strategy for Alzheimer's Disease
Tezapsidis, N., Johnston, J. M., Smith, M. A., Ashford, J. W., Casadesus, G., Robakis, N. K., Wolozin, B., Perry, G., Zhu, X., Greco, S. J., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1021 · Cited by 126
“products (RAGE) [46] and scavenger receptors [47];”
Signal Transduction in Receptor for Advanced Glycation End Products (RAGE)
Rai, V., Maldonado, A. Y., Burz, D. S., Reverdatto, S., Schmidt, A. M., & Shekhtman, A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.277731 · Cited by 125
Self-citationUddin, M. S., Kabir, M. T., Rahman, M. S., Behl, T., Jeandet, P., Ashraf, G. M., Najda, A., Bin-Jumah, M. N., El-Seedi, H. R., & Abdel-Daim, M. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165858 · Cited by 124
Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis
Caillier, S. J., Briggs, F. B. S., Cree, B., Baranzini, S. E., Fernández-Viña, M., Ramsay, P. P., Khan, O. A., Royal, W., Hauser, S. L., Barcellos, L. F., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.8.5473 · Cited by 141
Mechanism of glial activation by S100B: involvement of the transcription factor NFκB
Lam, A. G. M., Koppal, T., Akama, K. T., Guo, L., Craft, J. M., Samy, B., Schavocky, J. P., Watterson, D. M., & Eldik, L. J. V. (2001) · Neurobiology of Aging · doi:10.1016/s0197-4580(01)00233-0 · Cited by 128
Sorci, G., Riuzzi, F., Arcuri, C., Giambanco, I., & Donato, R. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.11.4880-4894.2004 · Cited by 125
Free radicals in Alzheimer’s disease
Retz, W., Gsell, W., Münch, G. W., Rösler, M., & Riederer, P. F. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-7508-8_22 · Cited by 129
RAGE regulates BACE1 and Aβ generation via NFAT1 activation in Alzheimer's disease animal model
Cho, H. J., Son, S. M., Jin, S. M., Hong, H. S., Shin, D. H., Kim, S. J., Huh, K., & Mook‐Jung, I. (2009) · The FASEB Journal · doi:10.1096/fj.08-126383 · Cited by 124
Metadata
- Authors
- Yan, S. D., Chen, X., Fu, J., Chen, M., Zhu, H., Roher, A., Slattery, T., Zhao, L., Nagashima, M., Morser, J., Migheli, A., Nawroth, P., Stern, D., & Schmidt, A. M.
- Affiliations
- Columbia University (US)
- University of Turin (IT)
- Heidelberg University (DE)
- Venue
- Nature
- Published
- 1996-08
- Volume
- 382
- Issue
- 6593
- Pages
- 685-691
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2049167261
- Cited by
- 2,012
- References
- 44
- Citations by year
- 2026: 28 · 2025: 33 · 2024: 44 · 2023: 46 · 2022: 56 · 2021: 48 · 2020: 59 · 2019: 58 · 2018: 65 · 2017: 55 · 2016: 77 · 2015: 75 · 2014: 81 · 2013: 93 · 2012: 100
- FWCI
- 58.19
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Clinical Biochemistry › Advanced Glycation End Products research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- receptor for advanced glycation end products, RAGE, amyloid-beta, neurotoxicity, Alzheimer's disease, microglial activation, oxidative stress, neuronal cell death, cell surface receptors, neuroinflammation
- MeSH terms
- Receptor for Advanced Glycation End Products, Alzheimer Disease, Animals, Base Sequence, Cattle, Cell Line, Cells, Cultured, Endothelium, Vascular, Humans, Molecular Sequence Data, Neurons, Receptors, Immunologic, Biomarkers, Amyloid beta-Peptides, PC12 Cells, Glycation End Products, Advanced, Microglia, DNA Primers, Oxidative Stress, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.